36353687|t|The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating.
36353687|a|Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 muM adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 muM ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.
36353687	39	43	E829	ProteinMutation	tmVar:p|Allele|E|829;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	48	52	R845	ProteinMutation	tmVar:p|Allele|R|845;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	166	171	TRPM2	Gene	7226
36353687	335	361	neurodegenerative diseases	Disease	MESH:D019636
36353687	396	401	TRPM2	Gene	7226
36353687	487	491	Ca2+	Chemical	-
36353687	528	533	TRPM2	Gene	7226
36353687	1029	1033	D820	ProteinMutation	tmVar:p|Allele|D|820;VariantGroup:2;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1035	1039	E829	ProteinMutation	tmVar:p|Allele|E|829;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1045	1049	R845	ProteinMutation	tmVar:p|Allele|R|845;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1052	1057	D820A	ProteinMutation	tmVar:p|SUB|D|820|A;HGVS:p.D820A;VariantGroup:2;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1059	1064	E829A	ProteinMutation	tmVar:p|SUB|E|829|A;HGVS:p.E829A;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1070	1075	R845A	ProteinMutation	tmVar:p|SUB|R|845|A;HGVS:p.R845A;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1159	1187	adenosine diphosphate-ribose	Chemical	MESH:D000246
36353687	1189	1193	ADPR	Chemical	MESH:D000246
36353687	1204	1208	Ca2+	Chemical	-
36353687	1210	1215	E829A	ProteinMutation	tmVar:p|SUB|E|829|A;HGVS:p.E829A;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1220	1225	R845A	ProteinMutation	tmVar:p|SUB|R|845|A;HGVS:p.R845A;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1281	1286	D820A	ProteinMutation	tmVar:p|SUB|D|820|A;HGVS:p.D820A;VariantGroup:2;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1345	1349	E829	ProteinMutation	tmVar:p|Allele|E|829;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1354	1358	R845	ProteinMutation	tmVar:p|Allele|R|845;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1408	1413	E829K	ProteinMutation	tmVar:p|SUB|E|829|K;HGVS:p.E829K;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1418	1423	R845D	ProteinMutation	tmVar:p|SUB|R|845|D;HGVS:p.R845D;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1493	1498	E829A	ProteinMutation	tmVar:p|SUB|E|829|A;HGVS:p.E829A;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1503	1508	E829K	ProteinMutation	tmVar:p|SUB|E|829|K;HGVS:p.E829K;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1556	1561	R845A	ProteinMutation	tmVar:p|SUB|R|845|A;HGVS:p.R845A;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1566	1571	R845D	ProteinMutation	tmVar:p|SUB|R|845|D;HGVS:p.R845D;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1625	1629	ADPR	Chemical	MESH:D000246
36353687	1663	1667	Ca2+	Chemical	-
36353687	1716	1720	E829	ProteinMutation	tmVar:p|Allele|E|829;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1766	1770	R845	ProteinMutation	tmVar:p|Allele|R|845;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1802	1806	Ca2+	Chemical	-
36353687	1869	1874	TRPM2	Gene	7226
36353687	1935	1939	E829	ProteinMutation	tmVar:p|Allele|E|829;VariantGroup:1;CorrespondingGene:7226;RS#:1282298847;CorrespondingSpecies:9606
36353687	1944	1948	R845	ProteinMutation	tmVar:p|Allele|R|845;VariantGroup:0;CorrespondingGene:7226;CorrespondingSpecies:9606
36353687	1982	1987	TRPM2	Gene	7226
36353687	2024	2029	TRPM2	Gene	7226
36353687	2092	2097	TRPM2	Gene	7226
36353687	2126	2152	neurodegenerative diseases	Disease	MESH:D019636
36353687	2230	2256	neurodegenerative diseases	Disease	MESH:D019636
36353687	Association	MESH:D000246	HGVS:p.R845A;CorrespondingGene:7226
36353687	Association	MESH:D000246	RS#:1282298847;HGVS:p.E829A;CorrespondingGene:7226
36353687	Association	MESH:D000246	HGVS:p.D820A;CorrespondingGene:7226
36353687	Association	MESH:D000246	CorrespondingGene:7226;CorrespondingSpecies:9606;VariantGroup:2;tmVar:p
36353687	Association	MESH:D019636	7226
36353687	Negative_Correlation	MESH:D000246	HGVS:p.R845D;CorrespondingGene:7226
36353687	Negative_Correlation	MESH:D000246	CorrespondingGene:7226;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p

